Characterization and biological effects of recombinant human erythropoietin - PubMed (original) (raw)
Characterization and biological effects of recombinant human erythropoietin
J C Egrie et al. Immunobiology. 1986 Sep.
Abstract
Human recombinant erythropoietin (rHuEPO) has been purified to apparent homogeneity and compared to purified human urinary erythropoietin (EPO). Both the purified natural and recombinant EPO preparations were characterized in a competition radioimmunoassay (RIA), the exhypoxic polycythemic mouse bioassay, in vitro tissue culture bioassays using bone marrow cells, and by Western analysis. In the immunological and biological activity assays, the rHuEPO shows a dose response which parallels that of the natural hormone. By Western analysis, the recombinant and human urinary EPO migrate identically. Administration of rHuEPO increases the hematocrit of normal mice in a dose-dependent manner. Additionally, the rHuEPO is able to increase the hematocrit of rats made uremic as a result of subtotal nephrectomy. In summary, by all criteria examined, the rHuEPO is biologically active and equivalent to the natural hormone.
Similar articles
- Biological characterization of recombinant human erythropoietin.
Krumwieh D, Arnold I, Seiler FR. Krumwieh D, et al. Behring Inst Mitt. 1988 Aug;(83):193-201. Behring Inst Mitt. 1988. PMID: 3240225 - Control of rHuEPO biological activity: the role of carbohydrate.
Elliott S, Egrie J, Browne J, Lorenzini T, Busse L, Rogers N, Ponting I. Elliott S, et al. Exp Hematol. 2004 Dec;32(12):1146-55. doi: 10.1016/j.exphem.2004.08.004. Exp Hematol. 2004. PMID: 15588939 - Comparison of relevant biological assays for the determination of biological active erythropoietin.
Krumwieh D, Arnold I, Seiler FR. Krumwieh D, et al. Dev Biol Stand. 1988;69:15-22. Dev Biol Stand. 1988. PMID: 3224764 - The relationship of erythropoietin and iron metabolism to red blood cell production in humans.
Adamson JW. Adamson JW. Semin Oncol. 1994 Apr;21(2 Suppl 3):9-15. Semin Oncol. 1994. PMID: 8202725 Review. - Development and characterization of novel erythropoiesis stimulating protein (NESP).
Egrie JC, Browne JK. Egrie JC, et al. Br J Cancer. 2001 Apr;84 Suppl 1(Suppl 1):3-10. doi: 10.1054/bjoc.2001.1746. Br J Cancer. 2001. PMID: 11308268 Free PMC article. Review.
Cited by
- Erythropoiesis-stimulating agents in elderly patients with anemia: response and cardiovascular outcomes.
Gowanlock Z, Sriram S, Martin A, Xenocostas A, Lazo-Langner A. Gowanlock Z, et al. Blood Adv. 2017 Aug 17;1(19):1538-1545. doi: 10.1182/bloodadvances.2017007559. eCollection 2017 Aug 22. Blood Adv. 2017. PMID: 29296795 Free PMC article. - The effect of erythropoietin on normal and neoplastic cells.
Elliott S, Sinclair AM. Elliott S, et al. Biologics. 2012;6:163-89. doi: 10.2147/BTT.S32281. Epub 2012 Jun 27. Biologics. 2012. PMID: 22848149 Free PMC article. - Erythropoietin: the developing story.
Cotes PM. Cotes PM. Br Med J (Clin Res Ed). 1988 Mar 19;296(6625):805-6. doi: 10.1136/bmj.296.6625.805. Br Med J (Clin Res Ed). 1988. PMID: 3130919 Free PMC article. No abstract available. - Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants.
Freise KJ, Widness JA, Veng-Pedersen P. Freise KJ, et al. J Pharmacol Exp Ther. 2010 Jan;332(1):229-37. doi: 10.1124/jpet.109.159905. Epub 2009 Oct 6. J Pharmacol Exp Ther. 2010. PMID: 19808699 Free PMC article. - Anemia of Chronic Diseases: Wider Diagnostics-Better Treatment?
Wiciński M, Liczner G, Cadelski K, Kołnierzak T, Nowaczewska M, Malinowski B. Wiciński M, et al. Nutrients. 2020 Jun 16;12(6):1784. doi: 10.3390/nu12061784. Nutrients. 2020. PMID: 32560029 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials